Looking at individual cases, we found half of LATE-like patients with tau-positive scans suggesting AD copathology and the other half being tau-negative (50% with tau limited in the MTL) suggesting LATE predominant pathology. This evidence concerns the gene MAPT and Alzheimer disease.